Pluri Inc. (NASDAQ:PLUR) Short Interest Update

Pluri Inc. (NASDAQ:PLURGet Free Report) saw a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 10,100 shares, a growth of 18.8% from the November 30th total of 8,500 shares. Approximately 0.3% of the company’s shares are short sold. Based on an average daily trading volume, of 25,800 shares, the days-to-cover ratio is presently 0.4 days.

Pluri Trading Down 0.7 %

Shares of PLUR stock traded down $0.03 on Tuesday, reaching $4.28. The company had a trading volume of 8,906 shares, compared to its average volume of 18,271. The stock has a market cap of $23.79 million, a PE ratio of -0.71 and a beta of 1.64. The company has a 50-day moving average of $4.89 and a 200-day moving average of $5.23. The company has a current ratio of 5.90, a quick ratio of 5.90 and a debt-to-equity ratio of 4.44. Pluri has a 12 month low of $4.07 and a 12 month high of $8.48.

About Pluri

(Get Free Report)

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.

Featured Stories

Receive News & Ratings for Pluri Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pluri and related companies with MarketBeat.com's FREE daily email newsletter.